Relationship between human papillomavirus infection and overexpression of p53 protein in cervical carcinomas and lymph node metastases

Journal of Medical Virology

Volumn 53, Issue 2, 1997, Pages 111-117

  Cavuslu, Saban ^a,b   Goodlad, John ^a,c   Hobbs, Carl ^a   Connor, Angela M ^a   Raju, K Shanti ^a   Best, Jennifer M ^a   Cason, John ^a,d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^c RAIGMORE HOSPITAL   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cervical carcinoma; Human papillomavirus; Metastases; p53 overexpression

Indexed keywords

PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA; WART VIRUS;

ADOLESCENT; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0030793725     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199710)53:2<111::AID-JMV2>3.0.CO;2-C     Document Type: Article

References (43)

1. Aguilar-Santelises M, Magnusson KP, Wiman KG, Mellstedt H, Jondal M (1994): Progressive B-cell chronic lymphocytic leukemia frequently exhibits aberrant p53 expression. International Journal of Cancer 58:474-479.
2. Bartek J, Bartkova J, Vojtesek B, Staskova Z, Lukas J, Rejthar A, Kovarik J, Midgely CA, Gannon JV, Lane DP (1991): Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 6:1699-1704.
3. Beyer-Finkler E, Girardi F, Sillem M, Pfister H (1995): Human papillomavirus DNA in genital cancers, metasteses and lymph nodes. Intervirology 38:173-180.
4. Bot FJ, Godschalk JCJ, Krishnadath KK, van der Kwast THM, Bosman FT (1994): Prognostic factors in renal cell carcinoma: Immunohistochemical detection of p53 protein vs. clinicopathological parameters. International Journal of Cancer 57:634-637.
5. Bushby-Earle RMC, Steel CM, Williams ARW, Cohen B, Bird CC (1994): p53 Mutations in cervical carcinogenesis-Low frequency and lack of correlation with human papillomavirus status. British Journal of Cancer 69:732-737.
6. Cavuslu S, Starkey WG, Kaye JN, Biswas C, Mant C, Kell B, Rice P, Best JM, Cason J (1996): Detection of human papillomavirus type-16 (HPV-16) DNA utilising microtitre plate based amplification reactions and a solid-phase enzyme immunoassay detection system. J. Virol Methods 53:59-69.
7. Cooper K, Herrington CS, Evans MF, Gate KC, McGee JO (1993): p53 Antigen in cervical condylomata, intraepithelial neoplasia, and carcinoma: Relationship to HPV infection and integration. Journal of Pathology 171:27-34.
8. Crook T, Wrede D, Vousden KH (1991): p53 Point mutation in HPV negative human cervical cell lines. Oncogene 6:873-875.
9. Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ, Vousden KH (1992): Clonal p53 mutation in primary cervical cancer: Association with human papillomavirus negative tumours. Lancet 339: 1070-1073.
10. de Re V, Carbone A, Devita S, Gloghini A, Maestro R, Gasparotto D, Vukosavljevic T, Boiocchi M (1994): p53 Protein overexpression and p53 gene abnormalities in HIV-1-related non-Hodgkins lymphomas. International Journal of Cancer 56:662-667.
11. de Villiers E-M (1992): Laboratory techniques in the investigation of human papillomavirus infection. Genitourinary Medicine 68:50-54.
12. El Awady MK, Kaplan JB, O'Brian SJ, Burk RD (1987): Molecular analysis of integrated human papillomavirus 16 sequences in the cervical cancer cell line SiHa. Virology 159:389-398.
13. Fuchs PG, Girardi F, Pfister H (1989): Human papillomavirus type 16 DNA in cervical carcinomas and in lymph nodes of cervical cancer patients: A diagnostic marker for early metasteses. International Journal of Cancer 43:41-44.
14. Helland A, Holm R, Kristensen G, Kaern J, Karlsen F, Trope C, Nesland JM, Borresen A-L (1993): Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas. Journal of Pathology 171:105-114.
15. Ikenberg H, Hartmann M, Schmitt B, Goppinger A, Teufel G, Pfleiderer A (1994): Human papillomavirus DNA in autopsy derived material from multiple metasteses of a cervical carcinoma. Gynecological Oncology 54:316-320.
16. Inoue M, Okayama A, Fujita M, Enomoto T, Sakata M, Tanizawa O, Ueshima H (1994): Clinicopathological characteristics of p53 over expression in endometrial cancers. International Journal of Cancer 58:14-19.
17. Jeffers MD, Richmond J, Farquharson M, McNicol AM (1994): p53 Immunoreactivity in cervical intraepithelial neoplasia and non-neoplastic cervical squamous epithelium. Journal of Clinical Pathology 47:1073-1076.
18. Kamel D, Paakko P, Pollanen R, Vahakangas K, Lehto VP, Soini Y (1995): Human papillomavirus DNA and abnormal p53 expression in carcinoma of the urinary bladder. APMIS 103:331-338.
19. Kaur J, Srivastava A, Ralhan R (1994): Overexpression of p53 in betel- and tobacco-related human oral dysplasia and squamous cell carcinoma in India. International Journal of Cancer 58:340-345.
20. Kaye JN, Cason J, Pakarian FB, Jewers RJ, Kell B, Bible JM, Raju KS, Best JM (1994): Viral load as a determinant for transmission of human papillomavirus type 16 from mother to child. Journal of Medical Virology 44:415-421.
21. Kessis TD, Slebos RJ, Han SM, Shah K, Bosch XF, Munoz N, Hedrick L, Cho KR (1993a): p53 Gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix. American Journal of Pathology 1453:1398-1405.
22. Kessis TD, Slebos RJ, Nelson WG, Kastan MB, Plunkett BS, Han SM, Lorincz AT, Hedrick L, Cho KR (1993b): Human papillomavirus 16 expression disrupts the p53-mediated cellular response to DNA damage. Poceedings of the National Academy of Sciences USA 90:3988-3992.
23. Lane DP (1994): p53 And human cancers. British Medical Bulletin 50:582-599.
24. Lipponen P, Eskelinen M, Hietala K, Syrjanen K (1994): Expression of proliferating cell nuclear antigen (PC10) p53 protein and c-erb-2 in renal adenocarcinoma. International Journal of Cancer 57:275-280.
25. Manos M, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM (1989): Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7:209-214.
26. Mittal KR, Lin O, Chan W, Goswami S, Demopoulos RI (1995): Cervical dysplasias and carcinomas with immunodetectable p53 frequently contain HPV. Gynecological Oncology 58:289-294.
27. Moyret-Lalle C, Marcais C, Jacquemier J, Moles J-P, Daver A, Soret J-Y, Jaenteur P, Ozturk M, Theillet C (1995): Ras, p53 and HPV status in benign and malignant prostate tumors. International Journal of Cancer 64:124-129.
28. Muir P, Nicholson F, Jhetam N, Neogi S, Banatvala JE (1993): Rapid diagnosis of enterovirus infections by magnetic bead extraction and polymerase chain reaction detection of enterovirus RNA in clinical specimens. Journal of Clinical Microbiology 31:31-38.
29. Mvula M, Iwasaka T, Matsuo N, Naao Y, Kaku T, Hachisuga T, Fukuda K, Tsukamoto N, Sugimori H (1994): Detection of human papillomavirus types 16 and 18 in primary and in metastatic lesions of cervical carcinomas. Gynecological Oncology 53:156-160.
30. Nawa A, Nishiyama Y, Kikkawa F, Kawai M, Mano H, Goto S, Suganuma N, Tomoda T, Nakashima N (1993): Detection of human papillomaviruses from histologically normal lymph nodes of Japanese cervical carcinoma patients by nested polymerase chain reaction assay. International Journal of Cancer 53:932-937.
31. Ngan HY, Stanley M, Liu SS, Ma HK (1994): HPV and p53 in cervical carcinoma. Genitourinary Medicine 70:167-170.
32. Oka K, Nakano T, Arai T (1993): p53 CM-1 expression is not associated with prognosis in uterine cervical carcinoma. Cancer 72:160-164.
33. Pakarian FB, Kaye JM, Cason J, Kell B, Jewers RJ, Raju KS, Best JM (1994): Cancer associated human papillomaviruses: Perinatal transmission and persistence. British Journal of Obstetrics and Gynaecology 101:514-517.
34. Park DJ, Wilczynski SP, Paquette RL, Miller CW, Koeffler HP (1994): p53 mutations in cervical carcinoma. Oncogene 9:205-210.
35. Pollanen R, Soini Y, Vahakangas K, Paako P, Lehto VP (1993): Aberrant p53 expression in cervical intraepithelial neoplasia. Histopathology 23:471-474.
36. Saiki RA, Bugawan TL, Horn GT, Mullis KB, Erlich HA (1986) Analysis of enzymatically amplified β-globin and HLA DQ alpha DNA with allele specific oligonucleotide probes. Nature 324:163-166.
37. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990): The E6 oncoprotein encoded by HPV-16 and 18 promotes degradation of p53. Cell 63:1129-1136.
38. Schneider A, Gadicke I, Schwartz E (1986): Different, human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. European Molecular Biology Organisation Journal 5:2285-2292.
39. van den Brule AJC, Meijer CJLM, Bakels V, Kenemans P, Walboomers JMM (1990): Rapid detection of human papillomavirus in cervical scrapes by combined general primer mediated and type-specific polymerase chain reaction. Journal of Clinical Microbiology 28:2739-2743.
40. Vojtesek B, Bartek J, Midgely CA, Lane DP (1992): An immunohistochemical analysis of the human nuclear phosphoprotein p53. Journal of Immunological Methods 151:237-244.
41. Wright DK, Manos MM (1990): Sample preparation from paraffin-embedded tissues. In Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds): "PCR Protocols: A Guide to Methods and Applications." San Diego: Academic Press, pp 153-158.
42. Yanuck MD, Kaufman RH, Woods KV, Alder-Storthz K (1991): Cervical carcinoma metastatic to the skull, heart and lungs: Analysis for HPV DNA. Gynecological Oncology 42:94-97.
43. zur Hausen H (1994): Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Current Topics in Microbiology and Immunology 186:131-156.